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Although a large body of evidence from
experimental and epidemiologic studies has
demonstrated the relationship between expo-
sure to vinyl chloride monomer (VCM) and
angiosarcoma [International Agency for
Research on Cancer (IARC) 1987; Lee et al.
1996], there is little evidence of a causal asso-
ciation between VCM and hepatocellular car-
cinoma (HCC) and liver cirrhosis (LC).
In their study on the U.S. cohort of VCM-
exposed workers, Mundt et al. (2000) found
an increased risk of liver cancer, mainly liver
angiosarcomas. In the study, however, they
distinguished HCC from angiosarcoma on the
basis of information on the cause of death
reported in death certiﬁcates. In the European
cohort of VCM workers, Ward et al. (2001)
searched for the best evidence of liver cancer
by reviewing all available documentation and
found a marked exposure–response relation-
ship for all liver cancers (71 cases), angio-
sarcoma (37 cases), and HCC (10 cases). This
evidence is also inconclusive because the num-
ber of HCC cases was small, there was a dis-
proportionate excess of liver cancers with
“other and unknown histology,” and the risk
estimates were not adjusted for the inﬂuence of
well-known risk factors for HCC: alcohol con-
sumption and viral infection. Recently Wong
et al. (2003) suggested an interaction between
occupational VCM exposure and hepatitis B
virus (HBV) infection in the development of
liver cancer.
Data on an association between VCM and
LC are even scarcer and are inconclusive. Du
and Wang (1998) reported a significantly
increased number of hospital admissions
among Taiwanese VCM workers due to pri-
mary liver cancer and cirrhosis of the liver. In
the European cohort of vinyl chloride workers,
Ward et al. (2001) reported that overall mor-
tality from cirrhosis was decreased, although
there was a trend toward an increase in cirrho-
sis mortality proportionate to an increase in
cumulative exposure. In this case, risk esti-
mates were not adjusted for the confounding
influence of alcohol consumption and HBV
infection.
Pirastu et al. (2003) reported on a cohort
of 1,658 workers employed in a VCM man-
ufacturing plant, in which the standardized
mortality ratio (SMR) for primary liver can-
cer of 2.78 was significantly increased.
Because cohort studies are unavoidably
affected by selection (healthy worker effect),
information (misclassification of exposure
and diagnosis of diseases based on death
certificate), and confounding biases [alcohol
intake, HBV/hepatitis C virus (HCV) carrier
status], we carried out a case–referent study
nested in the same cohort. In northeast Italy
(Porto Marghera, Venice), where the plant is
located, alcohol consumption is heavy and
viral hepatitis common. These particular
exposure conditions appeared suitable for the
appraisal of the individual role of VCM expo-
sure, alcohol intake, viral hepatitis infections,
and their interactions in the etiology of HCC
and LC.
Materials and Methods
The present case–referent study was carried
out on the occasion of a lawsuit by hundreds
of workers, local municipalities, and the
Italian national government against the VCM
plant management. At the beginning of the
lawsuit, the company indemniﬁed any health
problem that claimant workers themselves
attributed to their past exposure in the plant.
Among the “claimants” were 13 cases of
HCC [8 conﬁrmed by histology and 5 based
on the criteria recently issued by the Italian
Association for the Study of the Liver and the
British Society of Gastroenterology (Ryder
2003)—focal hepatic lesions at sonography
and α1-fetoprotein > 400 µg/L (Ryder 2003)],
and 40 cases of LC (24 with histologic conﬁr-
mation and 16 with clinical evidence of portal
hypertension, ascites, and/or esophageal
varices). Out of the 13 HCC cases, 11 also had
LC and are included in the series of LC cases.
We found information on diagnosis in
hospital records, which we actively searched
for deceased subjects (vital status and cause of
death were ascertained for all the cohort
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Hepatocellular carcinoma (HCC) and liver cirrhosis (LC) are not well-established vinyl chloride
monomer (VCM)–induced diseases. Our aim was to appraise the role of VCM, alcohol intake, and
viral hepatitis infection, and their interactions, in the etiology of HCC and LC. Thirteen cases of
HCC and 40 cases of LC were separately compared with 139 referents without chronic liver dis-
eases or cancer in a case–referent study nested in a cohort of 1,658 VCM workers. The odds ratios
(ORs) and the 95% conﬁdence intervals (CIs) were estimated by common methods and by ﬁtting
models of logistic regression. We used Rothman’s synergy index (S) to evaluate interactions. By
holding the confounding factors constant at logistic regression analysis, each extra increase of
1,000 ppm × years of VCM cumulative exposure was found to increase the risk of HCC by 71%
(OR = 1.71; 95% CI, 1.28–2.44) and the risk of LC by 37% (OR = 1.37; 95% CI, 1.13–1.69).
The joint effect of VCM exposure above 2,500 ppm × years and alcohol intake above 60 g/day
resulted in ORs of 409 (95% CI, 19.6–8,553) for HCC and 752 (95% CI, 55.3–10,248) for LC;
both S indexes suggested a synergistic effect. The joint effect of VCM exposure above 2,500 ppm
× years and viral hepatitis infection was 210 (95% CI, 7.13–6,203) for HCC and 80.5 (95% CI,
3.67–1,763) for LC; both S indexes suggested an additive effect. In conclusion, according to our
findings, VCM exposure appears to be an independent risk factor for HCC and LC interacting
synergistically with alcohol consumption and additively with viral hepatitis infection. Key words:
alcohol, case–referent studies, cirrhosis, hepatocellular carcinoma, occupational diseases, vinyl
chloride. Environ Health Perspect 112:1188–1192 (2004). doi:10.1289/ehp.6972 available via
http://dx.doi.org/ [Online 27 May 2004]
Environmental Medicine Articlemembers through 1999); incident cancer
cases (ascertained through the regional cancer
registry for all the cohort members from 1987
to 1999); and all other claimant workers.
Six hundred and forty-three former VCM
workers belonging to the above cohort were
examined from 1999 through 2002 by occupa-
tional physicians at the Occupational Health
Services (OHS) of two local health authorities
in the course of a medical surveillance program
launched by the Regione Veneto and the
Italian Ministry of Health. Among these sub-
jects, we identiﬁed 139 subjects without clinical
(including liver sonography) or biochemical
(normal serum levels of aspartate aminotrans-
ferase, alanine aminotransferase, and γ-glutamyl
transpeptidase) evidence of chronic liver disease
or cancer in any site. HCC cases and LC cases
were separately compared to the above 139 ref-
erents in the present cohort-based case–referent
study.
For cases, information on the job per-
formed and the corresponding entry/exit
dates was obtained from company files; for
referents, these data were obtained through
the occupational history collected by OHS
occupational physicians during the medical
surveillance program. Using a job–exposure
matrix developed by Pirastu et al. (1991), we
estimated cumulative VCM exposure by sum-
ming across the calendar years of exposure the
product of the average level of VCM exposure
in a job (parts per million) and years worked
in that job. The variable was split into four
classes using the quartiles (160, 500, and
2,500 ppm × years); it was also dichotomized
(cut point, 2,500 ppm × years) when examin-
ing interactions of VCM exposure with alco-
hol consumption or viral hepatitis infection.
We ascertained alcohol consumption in
cases and referents through hospital clinical
records and/or health surveillance records. The
measure was computed in grams of ethanol per
day. The variable was split into three classes
using 30 and 60 g/day as cut points; it was
also dichotomized [cut point, 60 g/day, a
threshold considered necessary for alcohol-
mediated injury (Donato et al. 2002)] in
examining interactions between VCM expo-
sure and alcohol consumption.
HBV and HCV chronic infection was
determined in cases and in referents by sero-
logic markers [HBV surface antigen (HbsAg)
and anti-HCV antibodies]. At analysis, the
variable was coded 1 in the presence of markers
for HBV and/or HCV, and 0 otherwise.
We defined “age” as the age reached by
each subject in 1999 (cases and referents) or at
death (cases only).
Interval variables were analyzed using
Student’s t-test and frequency variables ana-
lyzed using Fisher’s exact test. At univariate
analysis, the odds ratio (OR) and the exact
95% conﬁdence interval (CI) were estimated
using the StatXact statistical package (Mehta
and Patel 1999). When a variable was broken
down into classes, the lowest class was the ref-
erence subgroup at a conventional risk of 1.0.
We also calculated the chi-square test for linear
trend across ordered categories as described by
Breslow and Day (1980).
In order to evaluate interactions of VCM
exposure with alcohol intake or HBV/HCV
infections, we used the OR for joint exposure
(ORAB), the OR for exposure to a single factor
(ORA), and the OR for exposure to the other
single factor (ORB) to calculate the S synergy
index as S = (ORAB – 1) ÷ [(ORA +O R B)–2 ]
(Rothman 1986). The APAB proportion of dis-
ease attributable to the interaction was calcu-
lated as APAB = (S – 1) ÷ S. A multiple logistic
model was used to evaluate departure from
additivity, in which terms for confounding fac-
tors were also included (Rothman 1986).
Alcohol consumption (× 10), cumulative
VCM exposure (× 1,000), and HBV/HCV
carrier status were used as independent variables
in two models of stratiﬁed logistic regression
analysis (three strata of birth year), where the
dependent variable was 1 for cases (either
HCC or LC) and 0 for referents (always the
same 139 referents). Conditional maximum
likelihood estimate ORs with exact 95% CIs
and two-tailed probability of error were
obtained using the LogXact statistical package
(Mehta and Patel 2002).
Results
Table 1 shows the general characteristics of
13 HCC cases, 40 LC cases, and 139 refer-
ents. With respect to referents, cases were born
earlier (but they were younger because of early
death), were more exposed, and drank more
alcohol. The prevalence of drinkers was 92.3%
(12 of 13), 97.5% (39 of 40), and 73.4%
(102 of 139) in HCC, LC, and referents,
respectively. The prevalence of HBV/HCV
carriers was 23.1% (3 of 13), 17.5% (7 of
40), and 2.2% (3 of 139), in HCC, LC, and
referents, respectively.
Environmental Medicine | Vinyl chloride, hepatocellular carcinoma, and cirrhosis
Environmental Health Perspectives • VOLUME 112 | NUMBER 11 | August 2004 1189
Table 1. VCM cumulative exposure, alcohol consumption, demographic variables, and prevalence of
HBV/HCV infection in HCC cases, LC cases, and referents (Ref).
p-Valuea
HCC cases LC cases Ref HCC vs. Ref LC vs. Ref
No. of cases 13 40 139
VCM exposure (ppm × years) 4223.8 ± 2888.4 2845.3 ± 3041.7 1367.5 ± 2209.1 < 0.001 0.001
Alcohol (g/day) 90.8 ± 62.2 108.5 ± 53.2 29.1 ± 31.6 < 0.001 < 0.001
Year of hire 1960.5 ± 3.7 1961.8 ± 6.2 1964.9 ± 6.6 0.022 0.010
Year of birth 1933.2 ± 4.0 1930.9 ± 7.7 1935.5 ± 6.5 0.196 0.002
Age at death/end of follow-up 58.8 ± 4.5 59.6 ± 7.9 63.5 ± 6.5 0.013 0.010
HBsAg/HCV positive (%) 23.1 17.5 2.2 0.009 0.001
Values shown are mean ± SD except where indicated.
ap-Values for a two-tailed test (Student’s t-test for interval variables and Fisher’s exact test for frequency variable).
Table 2. HCC and LC risks in relation to cumulative VCM exposure, alcohol consumption, and viral hepatitis
infection at univariate analysis.
Cases (n) Ref (n)O R 95% CI χ2 for trend
HCC
VCM cumulative exposure
< 500 ppm × years 1 78 Reference
500–2,500 ppm × years 3 37 6.32 0.48–336.0
> 2,500 ppm × years 9 24 29.3# 3.61–1,298 16.1#
Alcohol consumption
< 30 g/day 1 82 Reference
30–60 g/day 4 46 7.13 0.67–355.0
> 60 g/day 8 11 59.6# 6.51–2,676 24.3#
HBsAg/HCV
Negative 10 136 Reference
Positive 3 3 13.6* 1.55–111.0
LC
VCM cumulative exposure
< 160 ppm × years 7 38 Reference
160–500 ppm × years 7 40 0.95 0.26–3.51
500–2,500 ppm × years 9 37 1.36 0.47–3.72
> 2,500 ppm × years 17 24 3.95** 1.56–9.98 8.06**
Alcohol consumption
< 30 g/day 1 82 Reference
30–60 g/day 7 46 12.5* 1.50–569
> 60 g/day 32 11 238# 31.2–9,820 78.1#
HBsAg/HCV
Negative 33 136 Reference
Positive 7 3 9.62** 2.03–59.6
Ref, referents.
*p < 0.05, **p < 0.01, and #p < 0.001 by two-tailed t-test.Table 2 shows the results at univariate
analysis. The ﬁrst two quartiles of cumulative
exposure collapsed because of missing HCC
cases. Increasing levels of cumulative VCM
and alcohol consumption significantly
increased the risks of HCC and LC. With
VCM exposure, the trend was steeper for
HCC than for LC, whereas the contrary
occurred with alcohol consumption. The sur-
prisingly high risk of HCC and LC in subjects
consuming > 60 g/day of alcohol suggested an
interaction with occupational exposure. Viral
hepatitis infection significantly increased the
risk of HCC and LC.
Table 3 shows a joint classification [by
cumulative VCM exposure lower or higher
than 2,500 ppm × years and a) alcohol con-
sumption lower or higher than 60 g/day or b)
viral hepatitis infection absent or present] of
HCC cases and referents. The conventional
risk of subjects unexposed to both of two risk
factors (reference category) being 1.0, the OR
estimating the effect of joint exposure to
VCM and alcohol was one order of magnitude
greater than the ORs estimating the effect of
each factor in the absence of the other.
Accordingly, the synergy index, which was
close to 7, indicated a departure from an addi-
tive relation. The proportion of HCC attrib-
utable to the interaction of VCM exposure
and alcohol consumption was as high as 85%.
The joint effect from VCM exposure and viral
hepatitis infection seemed less than multiplica-
tive, and S indicated only a moderate depar-
ture from an additive relation; the interaction
of two factors was responsible for 38% of the
HCC cases.
Table 4 shows a joint classification [by
cumulative VCM exposure lower or higher
than 2,500 ppm × years and a) alcohol con-
sumption lower or higher than 60 g/day or
b) viral hepatitis infection absent or present] of
LC cases and referents. The conventional risk
of subjects unexposed to both risk factors
being 1.0, the OR among subjects jointly
exposed to VCM and alcohol was close to the
product of ORs in those exposed to each factor
in the absence of the other. The synergy index
of 5 indicated a departure from an additive
relation, and the proportion of disease among
those with both exposures was 80%. The joint
effect from VCM exposure and viral hepatitis
infection (close to the sum of separate effects),
and the S index (close to unity) indicated an
additive relation.
Table 5 shows that by stratifying by ter-
tiles of the birth year of the cases, holding
constant the influence of HBV/HCV infec-
tion and alcohol intake, each extra increase of
1,000 ppm × years involved a 71% excess of
HCC risk or a 37% excess of LC risk.
Discussion
At the beginning of the trial, the company
granted compensation for any disease to all
employees, without ascertaining its occupa-
tional origin. Detailed information on this was
given by the labor union and the local media
during the trial (Mastrangelo et al. 2003).
From 1975 (when a cross-sectional study was
carried out) onward (during their employment
at the VCM plant), these workers underwent
yearly medical surveillance, which included
liver function tests. Using such records, all sub-
jects with liver function alteration or liver dis-
ease were identified in the course of trial.
Finally, mortality and incidence registers were
scrutinized. It is therefore reasonable to assume
that all cases of HCC and LC occurring in the
cohort were collected.
If exposure in referents had been higher
than, similar to, or lower than that in the
whole cohort, the HCC/LC risk would have
been underestimated, valid, or overestimated,
respectively. It is therefore important to con-
sider whether our method for selecting 
referents may have introduced a bias. The
mean ± SD of cumulative VCM was 1367.5
± 2209.1 ppm × years in our 139 referents and
1751.5 ± 2564.8 ppm × years in the remaining
504 VCM cohort workers in the medical sur-
veillance program. This difference is not statis-
tically significant (t = 1.61; p = 0.11). It is
therefore reasonable to deduct that ours is a
cohort-based case–referent study, in which the
selection of referents did not lead to an under-
estimation or overestimation of the risk of
HCC and LC. Nor was our study affected by
selection (healthy worker effect), information
(diagnosis of diseases based on death certifi-
cate), or confounding biases (alcohol intake,
HBV/HCV carrier status).
The main finding of the present study is
that VCM exposure is an independent risk fac-
tor for the development of HCC and LC. The
association between VCM exposure and HCC
was suggested in early studies showing the
coexistence of nodules of angiosarcoma and
hepatocarcinoma in histologic liver specimens.
Jones and Smith (1982) found angiosarcoma,
hepatocarcinoma, and hepatoadenoma nodules
in a worker who had been exposed to high
doses of VCM for several years. Furthermore,
Evans et al. (1983) reported the association of
cirrhosis, angiosarcoma, and hepatocarcinoma
in a subject exposed to VCM. This ﬁnding was
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Table 3. Distribution of HCC cases and referents (Ref) according to a joint classiﬁcation (VCM exposure
and alcohol consumption or viral hepatitis infection).
VCM < 2,500 ppm × years VCM > 2,500 ppm × years
Alcohol < 60 g/day
Cases/Ref 1/105 4/23
ORa (95% CI) Reference 18.8* (1.62–218.0)
Alcohol > 60 g/day
Cases/Ref 3/10 5/1
ORa (95% CI) 42.9** (3.41–540.0) 409# (19.6–8553.0)
Alcohol summary S = 6.83; AP = 85%
HbsAg/HCV negative
Cases/Ref 3/113 7/23
ORb (95% CI) Reference 25.0** (2.77–226.0)
HbsAg/HCV positive
Cases/Ref 1/2 2/1
ORb (95% CI) 106.9** (4.43–2578.0) 210.3** (7.13–6203.0)
HbsAg/HCV summary S = 1.61; AP = 38%
Abbreviations: AP, proportion of disease attributable to interaction; S, Rothman’s synergy index for interaction.
aOR adjusted for age and viral hepatitis infection. bOR adjusted for age and alcohol use. *p < 0.05, **p < 0.01, and #p < 0.001
by two-tailed t-test.
Table 4. Distribution of LC cases and referents (Ref) according to a joint classiﬁcation (VCM exposure and
alcohol consumption or viral hepatitis infection).
VCM < 2,500 ppm × years VCM > 2,500 ppm × years
Alcohol < 60 g/day
Cases/Ref 3/105 5/23
ORa (95% CI) Reference 6.64* (1.03–42.8)
Alcohol > 60 g/day
Cases/Ref 20/10 12/1
ORa (95% CI) 144.1# (24.1–860.0) 752.7# (55.3–10248.0)
Alcohol summary S = 5.05; AP = 80%
HbsAg/HCV negative
Cases/Ref 20/113 13/23
ORb (95% CI) Reference 8.22* (1.57–43.0)
HbsAg/HCV positive
Cases/Ref 3/2 4/1
ORb (95% CI) 67.2** (5.14–877.0) 80.5** (3.67–1763.0)
HbsAg/HCV summary S = 1.08; AP = 7%
Abbreviations: AP, proportion of disease attributable to interaction; S, Rothman’s synergy index for interaction. 
aOR adjusted for age and viral hepatitis infection. bOR adjusted for age and alcohol use. *p < 0.05, **p < 0.01, and
#p < 0.001 by two-tailed t-test.conﬁrmed by experimental studies in rats, in
which VCM exposure induced both angio-
sarcomas and hepatocarcinomas, the two
tumor types found in the same animal
(Froment et al. 1994). A recent study reported
on 18 HCC patients with long-term exposure
to VCM; all 18 patients lacked any further
identifiable risk factors for developing HCC
(Weihrauch et al. 2000). Confirmatory evi-
dence has been reported in a recent meta-
analysis combining the European and North
American cohorts of VCM workers (Boffetta
et al. 2003): liver cancers other than angio-
sarcoma resulted in a meta-SMR of 1.35
(95% CI, 1.04–1.77).
A multiplicative effect between VCM
exposure and alcohol in hepatocarcinogenesis
was found in an experimental study (Radike
et al. 1981). However, the present study is, to
our knowledge, the ﬁrst to report a synergistic
effect between VCM exposure in humans and
alcohol consumption in the development of
HCC and its associated preneoplastic condi-
tion, LC. An attributable proportion of nearly
80% indicates that VCM exposure and alcohol
intake have little effect separately but, in associ-
ation, produce most of the disease. This may
explain why the relationship between HCC (or
LC) and VCM has been overlooked in epi-
demiologic settings (where HCC cases would
be in excess only if alcohol intake were high in
VCM-exposed workers) and clinical settings
(where nonoccupational causes of disease are
often present).
The biologic interaction between VCM
and alcohol during hepatocarcinogenesis may
be due to several mechanisms. Alcohol is
prevalently metabolized in the liver by the
microsomal ethanol-oxidizing system (MEOS)
and alcohol dehydrogenase, leading to the gen-
eration of acetaldehyde and reactive oxygen
species (ROSs). Chronic alcohol consumption
is associated with an increased activity of
MEOS, which involves the specific P450
cytochrome CYP2E1 (Lieber and DeCarli
1970). An important feature of CYP2E1 is its
capacity to convert different xenobiotics into
highly toxic metabolites. VCM is primarily
metabolized in the liver by CYP2E1 (Stickel
et al. 2002) to chloroethylene oxide and chlor-
acetaldehyde, metabolites that can react with
DNA bases and promote mutations in bacter-
ial and mammalian cells (Marion and Boivin-
Angele 1999; Marion et al. 1996; Zhou et al.
2003). Thus, ethanol induction of CYP2E1
could contribute to hepatocarcinogenesis by
enhancing the conversion of VCM into toxic
intermediates. The induction of CYP2E1 is
also responsible for an increased catabolism of
retinoic acid (Leo and Lieber 1985). The
reduction of the hepatic concentration of
retinoids has been shown to be associated with
an up-regulation of the AP-1 (c-jun and c-fos)
transcriptional complex, leading to enhanced
cellular proliferation (Wang et al. 1998). By
sustaining parenchymal hyperproliferation,
alcohol (or viral infection) may act as a pro-
moter in VCM carcinogenesis. Acetaldehyde is
highly toxic and mutagenic and evidence has
accumulated that acetaldehyde is responsible
for alcohol associated carcinogenesis (Stickel
et al. 2002). ROSs promote lipid peroxidation
and react with DNA, resulting in alterations of
DNA structure. Besides these (carcinogenetic)
effects, ethanol and acetaldehyde could also
enhance VCM genotoxicity through the inhi-
bition of DNA–adduct removal (Singletary
et al. 2004).
In a cohort nested case–referent study,
18 cases of liver cancer and 68 referents
matched for age and speciﬁc plant of employ-
ment were selected from among 3,293 workers
from six polyvinyl chloride polymerization fac-
tories in Taiwan (Wong et al. 2003). Eighty-
nine percent of cancer cases had a history of
HBV infection, and none of the subjects was
a habitual alcohol drinker. With respect to
subjects unexposed to both risk factors, the
OR was 396.0 (95% CI, 22.6 to infinity)
among subjects jointly exposed (high VCM
exposure and viral hepatitis infection). The
latter OR was greater than the product of
ORs in those exposed to each factor in the
absence of the other, suggesting a synergistic
effect. By contrast, we found only an additive
effect of VCM cumulative exposure with viral
hepatitis on the risk of HCC while control-
ling for alcohol consumption. In our cases the
prevalence of drinkers was > 90%, and the
prevalence of HBV/HCV carriers was about
20%; whether the conﬂicting results might be
explained by the different distribution of risk
factors in the two working populations is
unclear.
Although the mechanism whereby VCM
exposure and viral hepatitis infection act addi-
tively is unknown, one hypothesis is that both
factors induce liver ﬁbrosis and regeneration,
which act as a tumor promoter in hepato-
carcinogenesis (Blendis et al. 2000; Pinzani
1999).
It is widely accepted that exposure to
increased concentrations of VCM causes liver
ﬁbrosis (Popper and Thomas 1975). Hepatic
ﬁbrogenesis, a dynamic tissue repair process, is
characterized by the increased synthesis of
extracellular matrix components and changes
in the perisinusoidal space (Pinzani 1995). If
the noxious agent persists, liver fibrosis pro-
gresses to cirrhosis. The rate of progression of
ﬁbrosis varies greatly from patient to patient,
and epidemiologic studies have identiﬁed sev-
eral cofactors related to the host. Alcohol con-
sumption is an important factor, with a
detrimental effect on liver ﬁbrosis. The activa-
tion of hepatic stellate cells is the common
pathway to liver fibrogenesis, and in vitro
studies have shown that acetaldehyde, a highly
reactive toxic product of alcohol metabolism,
can directly induce collagen gene transcription
and promote liver ﬁbrosis, even in the absence
of necro-inflammatory changes (Moshage
et al. 1990). Likewise, because of its structural
similarities, the VCM metabolite chlor-
acetaldehyde could directly sustain the pro-
gression of liver fibrosis (Larson and Bull
1991), thus explaining our finding of an
increased risk of LC after exposure to high
doses of VCM only. As suggested by several
studies performed in human hepatic stellate
cells [reviewed by Parola and Robino (2001)],
reactive aldehydes are able to directly induce
pro-collagen type I and III gene and protein
expression with a mechanism involving
nuclear translocation and activation of c-Jun
amino-terminal kinase (Parola et al. 1998).
Chronic alcohol consumption decreases
glutathione levels (Shaw et al. 1983), a reduc-
tive tripeptide, which inactivates both the
VCM hepatotoxic metabolites chloroethylene
oxide and chloracetaldehyde. Thus, VCM
exposure and alcohol intake may have a hyper-
additive effect in the progression to LC either
because of their intrinsic hepatotoxicity and
proﬁbrogenetic activity or because they com-
pete and/or deplete the reductive detoxiﬁcation
system.
HBV and HCV cause chronic liver dis-
ease, which can progress into cirrhosis.
However, not all hepatitis patients have this
complication, and genetic factors, alcohol
(Wiley et al. 1998), and obesity (Naveau
et al. 1997) may play a role. VCM exposure
could contribute to the development of LC
by the same mechanisms described for the
alcohol–hepatitis interaction.
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Table 5. HCC and LC risks in relation to cumulative VCM exposure, alcohol consumption, and viral hepatitis
infection.
OR (95% CI) p-Value
HCC
VCM exposure (ppm × years × 1,000) 1.71 (1.29–2.44) 0.0008
Alcohol consumption (g/day × 10) 1.36 (1.18–1.62) < 0.0001
HBsAg/HCV positive 46.6 (1.79–4960.0) 0.0141
LC
VCM exposure (ppm × years × 1,000) 1.37 (1.13–1.69) 0.0009
Alcohol consumption (g/day × 10) 1.70 (1.44–2.01) < 0.0001
HBsAg/HCV positive 33.9 (3.66–410.0) 0.0007
Estimates were obtained by means of conditional regression analysis for stratiﬁed data (strata, tertiles of year of birth):
OR, exact 95% CI, and exact error probability (p-value) for a two-tailed test.Environmental Medicine | Mastrangelo et al.
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In conclusion, according to our ﬁndings,
VCM exposure appears to be an independent
risk factor for HCC and LC interacting syner-
gistically with alcohol consumption and addi-
tively with viral hepatitis infection. This could
be relevant for new prevention strategies in
high-risk individuals.
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